Pain Management in Geriatric Hip Fracture

Overview

The Null Hypothesis is that there is no association between Pain regime and the functional performance among geriatric patients having traumatic hip fracture. Two limbs are being assessed:1. Three weeks of regular oral Panadol and Tramadol after hip fracture 2. Oral Panadol and tramadol taking in p.r.n. basis. Functional outcome including Numerical Rate Scale for pain assessment, Functional Independency Measure and Elderly Mobility Score are chosen.

Full Title of Study: “The Efficacy of Pain Management Protocol for Elderly Hip Fracture Patients After Surgery: A Prospective Cohort Study”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Non-Randomized
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: April 2012

Detailed Description

200X2 patients are recruited during two periods within the study period where regular oral analgesics is given for the first 200 patients while the rest of patient will receive oral analgesics upon demand

Interventions

  • Drug: Paracetamol tablet and Tramadol capsule
    • Panadol 500mg tablet Q4H prn Tramadol 50mg capsule Q4H prn
  • Drug: Panadol 500mg tablet, tramadol 50mg capsule
    • Regular Panadol 500mg tds with tramadol 50mg capsule tds for 3 weeks after injury

Arms, Groups and Cohorts

  • Experimental: Regular oral Panadol and Tramadol
    • Geriatric (age >65) Patient having traumatic hip fracture will have three weeks of regular prescription of oral Panadol(500mg) and tramadol (50mg) three times a day. Operation will be done within 3 days usually followed by rehabilitation period.
  • Experimental: Panadol and tramadol oral in prn basis
    • Control group is that patient having geriatric hip fracture will have oral analgesics ( Panadol 500mg Q4H and tramadol 50mg Q4H ) in prn basis.

Clinical Trial Outcome Measures

Primary Measures

  • Functional Independency Measure(FIM)
    • Time Frame: 2 years
    • FIM including motor and cognitive function of a patient. Motor area covers self care, ambulation, bowel and bladder and etc.
  • Elderly Mobility Score
    • Time Frame: 2 years
    • It is to assess mobility in frail elderly people. A final score rangeing from 0-20 is assigned during several time-point of rehabilitation

Participating in This Clinical Trial

Inclusion Criteria

  • Both sex of Age > 65
  • Traumatic non-pathological fracture neck of femur or trochanteric or subtrochanteric fracture having operative intervention

Exclusion Criteria

  • Age < 65
  • Pathological fracture
  • Multiple lower limb fractures
  • Old fracture

Gender Eligibility: All

Minimum Age: 65 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Queen Elizabeth Hospital, Hong Kong
  • Provider of Information About this Clinical Study
    • Principal Investigator: Ho Chin Hung, Associate Consultant (Orthopaedics and Traumatology) – Queen Elizabeth Hospital, Hong Kong
  • Overall Official(s)
    • Chin Ping Hong, Raymond, FRCSE(Edin), Study Director, Queen Elizabeth Hospital

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.